Post-approval studies (Phase 4)Study completedNCT00526630
What this trial is testing
Methylphenidate for the Treatment of Gait Impairment in Parkinson's Disease
Who this might be right for
Parkinson's DiseaseGait Impairment
University of Cincinnati 23